Changes to the Mental Capacity Act
An update on new legislation on mental capacity and making decisions about a person's health and care, which comes into force from April 2020.
Targeting nerve cell batteries to slow Parkinson’s progression
We’re investing nearly £1 million to find a new treatment that targets energy-producing mitochondria to slow the loss of brain cells in Parkinson's.
New research puts serotonin at the heart of Parkinson’s
In a seminal research paper, published in Lancet Neurology, researchers from King’s College London have used brain scans to uncover early changes in the brain that may happen years before the symptoms of Parkinson's appear.
HYPE protein found to target alpha-synuclein
Researchers in the US have identified a protein in the brain that may reduce the spread of the toxic alpha-synuclein protein in Parkinson's.
Targeting bacteria in the gut could increase effectiveness of levodopa
New research from Harvard University suggests changes to the gut could improve how a common Parkinson’s medication works.
New molecules targeting alpha-synuclein have potential for slowing Parkinson’s
Researchers in Japan have developed molecules that could be key to slowing the progression of Parkinson’s.
Employment and Parkinson's: share your experience in our survey
The government has committed to getting 1 million more disabled people into work by 2027. So we want to know what the barriers are for people with Parkinson's to get and stay in employment.
Parkinson’s outpatient clinic saved! Achub clinig claf allanol Parkinson’s!
Working closely with local volunteers, Parkinson's UK Cymru has successfully campaigned to save a Parkinson's outpatient clinic on the brink of closure.
Yn gweithio’n agos gyda gwirfoddolwyr lleol, mae Parkinson's UK Cymru wedi ymgyrchu’n llwyddiannus i achub clinig claf allanol Parkinson’s a oedd ar fin cau.
Existing drugs may help the brain protect itself against Parkinson's
Researchers at King's College London have investigated the properties of over 1,000 approved drugs to identify 2 with potential for Parkinson's.
New mouse model highlights promising potential drug for slowing Parkinson’s
The results indicate that, when given early, the molecule Anle138b may restore dopamine levels and help slow or stop Parkinson’s in its tracks.